Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...

CRISPR-Cas systems are adaptive immune systems found in prokaryotes that defend against invading nucleic acids through CRISPR ...

CRISPR Therapeutics (CRSP) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...

Turning genes on and off is like flipping a light switch, controlling whether genes in a cell are active. When a gene is ...

Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing ...

Scientists developed a new nanostructure that triples CRISPR’s ability to enter cells, unlocking even more power to treat ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

That’s why a team from UC San Diego in La Jolla set out with Yale University researchers to develop a new system for gene ...

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $60.62, marking a -2.38% move from the previous day.

Over the past few decades, biomedical researchers and neuroscientists have devised increasingly advanced techniques to study ...